Plus   Neg

BTG FY Product Sales At Upper End Of Its Prior Outlook - Quick Facts

BTG plc (BTG.L) issued an update for the 12 months ended 31 March 2019, revealing product sales at the top end of the Board's view. Oncology and Vascular sales are in line with the Board's projected growth range of 15-17%. Pharmaceuticals recorded double-digit growth, ahead of the company's outlook of low single digit growth. Licensing revenues are broadly flat with previous year, the Group said.

BTG plc said its Board continues to expect that the acquisition of BTG by Boston Scientific unit, which remains subject to the satisfaction or waiver of certain conditions, to close around the middle of the calendar year 2019.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Apotex Corp. recalled all lots of type 2 diabetes medication Metformin hydrochloride in the form of oral film-coated tablets for the potential presence of nitrosamine impurity, N-Nitrosodimethylamine (NDMA), above levels of the Acceptable Daily Intake Limit (ADI), the U.S. Food and Drug Administration or FDA said in a statement. Groupe Renault plans to cut about 14,600 jobs across the world and lower its production capacity. The plan includes almost 4,600 jobs reduction in France, through voluntary retirement and retraining. Amazon said it will convert 125,000 of the 175,000 temporary workers it hired in March amid the coronavirus pandemic, to permanent full-time employees in June. The e-commerce giant had hired the temporary employees in March to meet strong consumer demand amid the lockdown. The job openings were in Amazon's fulfillment centers and its delivery network.
Follow RTT